Home | Structured Search | Drug Resource
Find: within
Diabetic Ketoacidosis > Drug Therapy Author: Heather Lochnan, MD
Approved for review - 2009-03-25
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Insulin is required to treat the hyperglycemia and ketosis.
  • Insulin results in a shift of potassium from the extracellular space to the intracellular space; therefore, treatment with insulin in the hypokalemic patient could result in profound hypokalemia and serious arrhythmias.
  • Insulin therapy is required to suppress ketosis.
  • Inadequate therapy results in prolongation of the ketosis and elevation in anion gap.

Evidence:

  • Early reduction in insulin therapy because of normalization of blood glucose will prolong the duration of DKA (23).
  • Low-dose insulin therapy is as effective as older high-dose regimens (24).
  • DKA can be treated without initial bous of regular insulin (25).
  • Rapid-acting insulin analogs are as efficacious as regular insulin in mild-to-moderate DKA (26; 27; 28).

Comments:

  • Cardiac monitoring may give an indication of potassium concentration and allow early administration of insulin if there is evidence of hypokalemia.

FAQs
Ebenezer A. Nyenwe, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Heather Lochnan, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.